Analysts: Endocyte Inc (ECYT.OQ)

ECYT.OQ on NASDAQ Stock Exchange Global Select Market

18.80USD
1 Aug 2013
Price Change (% chg)

$0.83 (+4.62%)
Prev Close
$17.97
Open
$18.12
Day's High
$18.86
Day's Low
$18.03
Volume
94,419
Avg. Vol
77,789
52-wk High
$18.86
52-wk Low
$7.50

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.10 December 2 Aug 2013

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 3 3
(2) OUTPERFORM 4 4 3 3
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.86 1.86 1.71 1.71

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 7 15.17 17.20 12.88 0.30
Quarter Ending Dec-13 7 19.25 37.96 15.00 3.60
Year Ending Dec-13 7 64.06 85.88 57.81 14.67
Year Ending Dec-14 6 77.75 117.80 43.20 34.73
Earnings (per share)
Quarter Ending Sep-13 6 -0.10 -0.02 -0.16 -0.28
Quarter Ending Dec-13 6 -0.00 0.51 -0.15 -0.19
Year Ending Dec-13 7 -0.32 0.35 -0.47 -0.96
Year Ending Dec-14 7 -0.17 0.59 -1.08 -0.62

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 14.24 14.51 0.28 1.95
Quarter Ending Dec-12 13.61 14.45 0.84 6.19
Quarter Ending Sep-12 12.96 12.41 0.55 4.21
Quarter Ending Jun-12 27.12 7.81 19.30 71.19
Quarter Ending Mar-12 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 15.17 15.17 15.17 15.17 0.30
Quarter Ending Dec-13 19.25 19.25 19.25 19.25 3.60
Year Ending Dec-13 64.06 64.06 64.06 64.06 14.67
Year Ending Dec-14 77.75 77.75 77.75 77.75 34.73

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-13 0 0 0 0
Quarter Ending Dec-13 0 0 0 0
Year Ending Dec-13 0 0 0 0
Year Ending Dec-14 0 0 0 0
Earnings

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: GlobalData
$250.00
Provider: Reuters Investment Profile
$20.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks